S&P 500$7,515.34
-0.79%
2m
DOW 30$52,498.64
-0.26%
2m
NASDAQ 100$29,264.10
-1.88%
2m
Russell 2000$293.48
-0.85%
2m
Russell 1000$410.01
-0.75%
2m
S&P 400$3,758.76
-0.56%
2m
S&P 600$1,762.76
-0.39%
2m

Arrowhead Phrmct (ARWR)

NASDAQ

$74.99+$0.88 (+1.19%)

Price as of Jul 13, 2026 7:59 PM EDT

$10.8B
Market Cap
298.23%
1-Year Change
Biotechnology
Industry

Annual

Quarterly

	09/30/2025	09/30/2024	09/30/2023	09/30/2022
Income Statement
Total Operating Revenue	829.4M +23,258.15%	3.6M -98.52%	240.7M -1.03%	243.2M +75.89%
Cost of Revenue	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Gross Profit	829.4M +23,258.15%	3.6M -98.52%	240.7M -1.03%	243.2M +75.89%
Sales and Marketing Expense	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Research and Development Expense	-607.2M +20.02%	-505.9M +43.23%	-353.2M +18.80%	-297.3M +44.08%
Depreciation and Amortization Expense	23.9M +28.68%	18.6M +48.84%	12.5M +19.88%	10.4M +26.06%
Total Operating Expenses	731.1M +20.92%	604.6M +35.65%	445.7M +5.69%	421.7M +46.78%
Operating Profit	98.3M +116.36%	-601.1M +193.21%	-205.0M +14.84%	-178.5M +19.77%
Interest Income	37.3M +64.12%	22.7M +48.51%	15.3M +445.19%	-4.4M N/A
Interest Expense	-63.3M +579.67%	-9.3M -49.16%	-18.3M N/A	N/A N/A
Interest Income and Expense and Net	-26.0M -294.26%	13.4M +542.78%	-3.0M -31.70%	-4.4M N/A
Total Nonoperating Income and Expense	-46.8M +311.36%	-11.4M +664.27%	-1.5M -125.68%	5.8M -29.21%
Income before Taxes	51.5M +108.41%	-612.5M +196.60%	-206.5M +19.56%	-172.7M +22.62%
Income Taxes	21.4M +874.09%	-2.8M -199.39%	2.8M -26.45%	3.8M +189,150.00%
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-1.6M -99.73%	-599.5M +192.04%	-205.3M +16.59%	-176.1M +25.00%
Net Income from Continuing Operations Applicable to Common	51.5M +108.41%	-612.5M +196.60%	-206.5M +19.56%	-172.7M +22.62%
Basic EPS and Net Income	-0.01 -99.80%	-5.00 +160.42%	-1.92 +14.97%	-1.67 +22.79%
Diluted EPS and Net Income	-0.01 -99.80%	-5.00 +160.42%	-1.92 +14.97%	-1.67 +22.79%
Basic Weighted Average Shares	133.8M +11.67%	119.8M +12.21%	106.8M +1.26%	105.4M +1.62%
Diluted Weighted Average Shares	133.8M +11.67%	119.8M +12.21%	106.8M +1.26%	105.4M +1.62%
Balance Sheet
Cash and Cash Equivalents	88.7M -13.61%	102.7M -7.40%	110.9M +2.67%	108.0M -41.44%
Short-Term Investments	692.8M +19.81%	578.3M +97.54%	292.7M N/A	0 -100.00%
Cash and Cash Equivalents and Short-Term Investments	781.5M +14.77%	681.0M +68.71%	403.6M +273.71%	108.0M -65.29%
Total Current Assets	950.6M +36.69%	695.5M +65.78%	419.5M +3.51%	405.3M +5.38%
Accumulated Depreciation	80.2M +38.17%	58.0M +38.31%	42.0M +32.95%	31.6M +38.01%
Property and Plant and Equipment and Net	382.5M -0.91%	386.0M +32.99%	290.3M +163.16%	110.3M +126.60%
Total Long-Term Assets	1.4M -69.01%	4.5M +2,034.29%	210,000 -3.67%	218,000 -19.85%
Total Assets	1.4B +21.54%	1.1B +48.89%	765.6M +10.64%	691.9M -2.56%
Income Taxes Payable	20.8M N/A	N/A N/A	N/A N/A	N/A N/A
Total Short-Term Debt	40.0M -90.00%	400.0M N/A	N/A N/A	N/A N/A
Total Current Liabilities	195.5M +89.48%	103.2M -2.17%	105.5M -24.05%	138.8M -5.25%
Total Long-Term Debt	214.9M -45.35%	393.2M N/A	N/A N/A	N/A N/A
Total Long-Term Liabilities	686.4M -18.83%	845.6M +126.73%	372.9M +176.76%	134.8M -12.95%
Total Liabilities	299.6M +39.87%	214.2M +1.97%	210.1M -3.49%	217.7M +28.16%
Retained Earnings	-1.6B +0.10%	-1.6B +58.43%	-1.0B +25.01%	-820.8M +27.31%
Total Stockholders Equity	466.1M +151.32%	185.4M -31.66%	271.3M -31.91%	398.5M -2.52%
Total Shares Outstanding	135.7M +9.11%	124.4M +15.90%	107.3M +1.28%	106.0M +1.57%
Cash Flow
Cash from Operating Activities	179.6M +138.79%	-462.9M +200.77%	-153.9M +13.05%	-136.1M -179.50%
Capital Expenditures	22.7M -83.98%	141.5M -19.96%	176.7M +234.88%	52.8M +123.94%
Cash from Investing Activities	-129.3M -69.22%	-420.1M +336.87%	-96.2M +1,675.06%	-5.4M -96.18%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	74.0M -91.50%	870.5M +244.01%	253.1M +288.20%	65.2M +476.61%
Financials Ratio
Gross Margin	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Operating Margin	11.86% +100.07%	-16,927.06% +19,777.55%	-85.16% +16.03%	-73.39% -31.90%
Return on Assets	-0.13% -99.79%	-62.93% +123.40%	-28.17% +12.16%	-25.11% +9.90%
Return on Equity	-0.50% -99.81%	-262.48% +328.27%	-61.29% +40.52%	-43.62% +34.80%
Revenue Growth	23,258.15% +23,706.37%	-98.52% +9,500.95%	-1.03% -101.35%	75.89% +32.77%
Current Ratio	4.86 -27.86%	6.74 +69.45%	3.98 +36.29%	2.92 +11.22%
Cash Ratio	0.45 -54.41%	1.00 -5.34%	1.05 +35.17%	0.78 -38.19%
Debt-to-Equity Ratio	0.55 -87.21%	4.28 N/A	N/A N/A	N/A N/A
Debt-to-Assets Ratio	0.18 -73.56%	0.70 N/A	N/A N/A	N/A N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow